Making Science Group (MAKS) Investor day 2026 presentation summary
Event summary combining transcript, slides, and related documents.
Investor day 2026 presentation summary
17 May, 2026Company overview and market positioning
Operates as a global digital acceleration and marketing technology consulting firm with over 800 employees in 18 countries, focusing on digital advertising, cloud for marketing, AdTech, and MarTech.
Recognized among Europe's fastest-growing companies, with a projected revenue of €374M and recurring EBITDA of €14M in 2025.
Business lines include a global digital agency, AI-driven technology division, AI venture studio (AWAKE), and an investment area for business diversification.
Serves major global clients across industries and partners with leading technology platforms such as Google, Meta, and Microsoft.
Financial performance and transformation
Revenue projected to grow from €274M in 2024 to €374M in 2025, driven by US and UK client reselling and service activity expansion.
Recurring EBITDA remains stable year-over-year, reflecting investments in talent and client portfolio changes.
Q1 2026 revenue up 20% year-over-year to €97.2M, with gross margin and EBITDA also increasing.
Disciplined debt management, with net financial debt expected to decrease by 78% from 2025 to 2026.
Business line performance
Tech-enabled digital agency saw a 26% revenue increase in Q1 2026, with strong performance in the US, UK, Nordics, and new markets.
AWAKE venture studio experienced a 40% revenue decline but improved EBITDA due to efficiency gains in Georgia.
Raising AI business posted a 46.5% revenue increase but lower EBITDA due to expansion costs.
Investment segment remained stable in revenue but EBITDA hovered around break-even due to macroeconomic factors.
Latest events from Making Science Group
- Q1 2026 revenue up 20% to €97.2M, EBITDA up 8.5%, and €2M dividend paid.MAKS
Q1 20267 May 2026 - FY 2025 revenue rose 36% to €374M, EBITDA stable, net debt down 78%, focus shifts to digital and AI.MAKS
Q4 202516 Mar 2026 - H1 2025 revenue up 40% to €174.6M, recurring EBITDA €7.7M, international share at 60%.MAKS
Q2 20252 Nov 2025 - Recurring EBITDA nearly doubled in H1 2024, led by strong Spain and international growth.MAKS
Q2 202411 Jul 2025 - Recurring EBITDA up 94% to €10.6M in 9M24, with robust growth and margin expansion.MAKS
Q3 202411 Jul 2025 - 2024 saw 16% revenue growth and 71% EBITDA surge, with strong international momentum.MAKS
Q4 202411 Jul 2025 - Record Q1 2025 EBITDA and 33% revenue growth driven by strong international expansion.MAKS
Q1 202511 Jul 2025 - Record Q1 2025 EBITDA and rapid international growth highlight strong execution and AI-driven strategy.MAKS
Investor Presentation11 Jul 2025